Form 4: Ulta Beauty Director George Mrkonic Jr. Receives Restricted Stock Unit Grant
Insider Transaction Report
Ulta Beauty, Inc. Director George R. Mrkonic Jr. was granted 383 restricted stock units (RSUs) on June 11, 2025, as part of his compensation.
Summary
- Ulta Beauty, Inc. (ULTA) Director George R. Mrkonic Jr. reported the acquisition of 383 shares of common stock.
- The transaction, dated June 11, 2025, was a grant of restricted stock units (RSUs) with a price of $0 per share.
- These 383 restricted stock units are scheduled to vest 100% on June 11, 2026.
- Following this transaction, Mr. Mrkonic beneficially owns a total of 2,835 shares of Ulta Beauty common stock.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as the RSU grant aligns the director's interests with shareholders, indicating continued commitment and a standard compensation practice. It is not highly impactful but generally viewed favorably.
Positives
- The grant of restricted stock units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
- An increase in beneficial ownership by a director, even through a grant, can signal confidence in the company's future prospects.
Future Outlook
The granted restricted stock units are set to vest fully on June 11, 2026, indicating a future milestone for the director's compensation.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically a compensation grant, which is common practice across all industries for public company directors and executives. It does not provide specific insights into the broader beauty retail industry trends but reflects standard corporate governance and compensation practices within the sector.
Comparison to Industry Standards
- The grant of restricted stock units (RSUs) as part of director compensation is a common practice among publicly traded companies, including those in the retail and beauty sectors, such as Sephora (owned by LVMH), Estée Lauder (EL), and L'Oréal (OR.PA).
- The vesting schedule of one year (100% on 6/11/2026) for director RSU grants is within typical industry norms, which often range from immediate vesting to multi-year schedules, depending on the company's compensation philosophy and governance practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of 383 restricted stock units to Director George R. Mrkonic Jr. as part of his compensation package. | 06/11/2025 | This grant aligns the director's financial interests with the long-term performance of Ulta Beauty's stock, reinforcing good corporate governance by incentivizing value creation for shareholders. |
Related Party Transactions
- The grant of restricted stock units to Director George R. Mrkonic Jr. constitutes a related party transaction, as it involves the company providing compensation to a member of its board of directors.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's incentives with shareholder value, potentially leading to more focused decision-making aimed at increasing stock price.
- Employees: No direct impact on general employees is indicated by this specific filing.
Next Steps
- The 383 restricted stock units granted to Director George R. Mrkonic Jr. are expected to vest on June 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of grant of 383 restricted stock units to Director George R. Mrkonic Jr. |
| 06/11/2026 | Vesting date for 100% of the 383 restricted stock units granted to Director George R. Mrkonic Jr. |
| 06/12/2025 | Date the Form 4 was signed by Paula M. Oyibo, as attorney-in-fact for George R. Mrkonic. |
Keywords
Ulta Beauty, ULTA, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Corporate Governance, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.